FDA permits marketing of first direct-to-consumer genetic carrier test for Bloom syndrome

February 19, 2015Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today authorized for marketing 23andMe’s Bloom Syndrome carrier test, a direct-to-consumer (DTC) genetic test to determine whether a healthy person has a variant in a gene that could lead to their offspring inheriting the serious disorder.

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA permits marketing of first direct-to-consumer genetic carrier test for Bloom syndrome